JPRN-UMIN000042017暂停未知
Hydrogen gas inhalation randomized double blinded trial for ulcerative colitis - Hydrogen gas inhalation randomized double blinded trial for ulcerative colitis
适应症
试验速览
- 阶段
- 未知
- 状态
- 暂停
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •All cases with liver disease, kidney disease, heart disease, or other serious complications. Lactating women, pregnant women, and all cases of possible pregnancy. Patients with respiratory diseases such as chronic obstructive respiratory disease and asthma.
研究者
相似试验
已完成
不适用
Hydrogen gas inhalation randomized double blinded trial for Parkinson's diseases diseaseParkinson's diseaseJPRN-UMIN000035602Juntendo University Koshigaya Hospital20
进行中（未招募）
1 期
Ensayo randomizado, doble ciego, con doble enmascaramiento, de grupos paralelos para evaluar la eficacia y seguridad de RO4402257 como monoterapia en comparación con la monoterapia de metotrexato para pacientes con artritis reumatoide activa (AR)A randomized, double-blind, double-dummy, parallel group study to determine the efficacy and safety of RO4402257 monotherapy in comparison to methotrexate monotherapy in patients with active rheumatoid arthritis (RA).EUCTR2005-003694-25-ESF. Hoffmann-La Roche Ltd200
尚未招募
4 期
AMBLE Trial: Iron Deficiency Anaemia in Major Cardiac, Abdominal and VascuLar surgery patients and Effect on functional outcomesACTRN12622001447741South Metropolitan Health Service240
进行中（未招募）
1 期
Human Rhinovirus (HRV16) challenge study of PrEP-001 in Asthmatic Subjects.Human Rhinovirus (HRV-16)MedDRA version: 18.0 Level: PT Classification code 10075163 Term: Human rhinovirus test System Organ Class: 10022891 - InvestigationsEUCTR2015-004042-26-GBhVIVO Services Limited40
进行中（未招募）
不适用
Etude randomisée, en double aveugle, évaluant l'efficacité et la tolérance de l'analgésie par mélange équimolaire protoxyde d'azote-oxygène contre oxygène chez des patients bénéficiant d'injection endovésicale de toxine botulique de type A - PROTOTOXPatient présentant une hyperactivité vésicale neurologique et bénéficiant d'injection endovésicale de toxine botulique de type AMedDRA version: 8.1Level: PTClassification code 10002182Term: Hyperactivité vésicale neurologiqueEUCTR2006-005352-32-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)